Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2021-11-09

FDA Approved: ARFORMOTEROL TARTRATE — Original Application (Teva Pharmaceuticals USA, Inc.)

View source ↗

Summary

FDA approved Teva's original-application generic ARFORMOTEROL TARTRATE (arformoterol tartrate) for inhalation under an original ANDA.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ARFORMOTEROL TARTRATE (arformoterol tartrate)

Snippet

ORIG AP for ARFORMOTEROL TARTRATE (ARFORMOTEROL TARTRATE)